Dean Riggott Photography
Surescripts
Improve access with automation & reporting
When prior authorization depends on faxes, phone calls and a maze of separate portals, patient access to your breakthrough treatments can be delayed for days or weeks. Meanwhile, brand teams struggle to spot and make sense of prior authorization trends that impact access and commercial performance.
That changes when you partner with Surescripts. Our Prior Authorization Platform for Life Sciences helps cut determination time and delays for your brands—enabling faster patient access and delivering insights that validate and improve performance.
83% of prescribers
say prior authorization is the biggest impediment to improving speed to therapy.
22 seconds
median approval time for prior authorizations fully automated by Surescripts
68% fewer
denials due to lack of information for prior authorizations automated by Surescripts
What can the Prior Authorization Platform do for you?
See how the Prior Authorization Platform for Life Sciences helps you get medications to patients more effectively.
Anticipate & overcome prior authorization barriers for your brands
Get prior authorization metrics so you can understand how prior authorization affects access to your therapies. Then, we’ll deploy prior authorization automation for your therapies that reduces room for error and often delivers determinations almost instantly—making it possible for patients to get your branded medications the same day they’re prescribed.
Reduce treatment delays
Manual prior authorizations can take days or weeks. We can replace this process with advanced automation that finds the smartest path to a determination.
Automate determinations
In many cases, Surescripts can launch prior authorization at the point of prescribing, automatically retrieve clinical data and deliver determinations in under 30 seconds.
Propel strategy decisions
How is prior authorization impacting the patients you serve? Get a clearer view with data that can help shape patient access strategies and optimize commercial performance.
Tap into powerful network effects
As the nation’s leading health intelligence network, Surescripts is deeply embedded in prescriber and pharmacy benefit manager (PBM) workflows.
How it works for life sciences companies
Surescripts supplies metrics on the state of prior authorization for your brand.
Get unprecedented visibility into prior authorization barriers with metrics like transaction volumes and drop-off rates.
Surescripts deploys automation to accelerate prior authorization for your therapies.
Our automation is designed to eliminate delays in demonstrating medical necessity and making determinations.
Thanks to our partnership, your medications can reach patients faster.
A faster path to therapy sets the stage for better adherence and greater confidence in patients’ treatment plans.
Find out more about the Prior Authorization Platform for Life Sciences
Why do prior authorizations often take so long?
In a survey about prior authorization barriers, prescribers named limited or delayed health plan responses and limited provider resources as the biggest prior authorization challenges. For their part, 81% of pharmacists also said that getting a response from the prescriber is a major impediment.
How does Surescripts speed up prior authorization decisions?
Deeply embedded in prescriber and PBM workflows, Surescripts prior authorization technologies leverage both clinical insights and benefit intelligence. This unique combination lets us streamline the prior authorization process in order to reach decisions as quickly as possible—often without the need for manual work. This can include:
- Proactively checking whether new prescriptions require prior authorization and initiating the process at the point of prescribing
- Answering question sets with clinical values from the patient’s electronic health record (EHR) and sending them to the PBM for approval
- Automatically gathering additional types of clinical information from sources such as clinical notes to answer more complex requests
- Analyzing question sets in order to automatically submit requests to PBMs who haven’t yet implemented automation
For brands supporting Surescripts Prior Authorization Platform for Life Sciences, prior authorization is identified and initiated automatically based on the electronic prescription. By handling prior authorization automatically at the point of prescribing, we often make it possible to go from prescription to fulfillment in the space of a single day.
How is Surescripts different from other prior authorization companies?
Unlike solutions that simply digitize existing prior authorization workflows—or shift the workload to third parties—Surescripts is transforming prior authorization through automation that leverages deep clinical insights from our nationwide network.
Through the Prior Authorization Platform for Life Sciences, we can partner to not just digitize but remove steps from the process. With unique, real-time access to clinical intelligence, benefit information and connections to providers and PBMs, we can frequently eliminate the need for steps such as data entry and manual review.